Preparation method of high-purity tolvaptan

A tolvaptan, high-purity technology, applied in the field of drug preparation, can solve the problems of dechlorination impurity residue, inability to completely inhibit dechlorination reaction, and inability to obtain high-purity tolvaptan, and achieve the effect of high yield

Inactive Publication Date: 2018-02-06
CHANGZHOU SUNLIGHT PHARMA
View PDF6 Cites 6 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the methods proposed in these two documents cannot completely inhibit the occurrence of dechlorination reaction, and

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of high-purity tolvaptan
  • Preparation method of high-purity tolvaptan

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1）

[0031] The preparation method of the high-purity tolvaptan of the present embodiment is as follows:

[0032] Add 5g of the compound of formula II into a 100mL three-neck flask, then add 25mL of tetrahydrofuran, stir to dissolve, cool down to -5~0°C, control the temperature at -5~0°C, and dropwise add 1.73g of dihydrofuran with a concentration of 70wt%. Hydrogen bis(2-methoxyethoxy)sodium aluminate toluene solution, heat up to 10-20°C after addition, and stir for 2 hours.

[0033] After the completion of the reaction monitored by HPLC, the temperature was controlled at 10-20°C, and 50mL of water was added dropwise. Solids were precipitated. Stirring was continued for 1-2h, and suction filtration was performed. The filter cake was recrystallized with methanol aqueous solution, and dried under reduced pressure to obtain white crystals of tolvaptan. 4.73g, the yield was 94.2%, the HPLC purity was 99.97%, and the dechlorinated impurity IV was not detected.

Embodiment 2～ Embodiment 6）

[0035] The preparation method of each embodiment is basically the same as that of Example 1, and the differences are shown in Table 1.

[0036] Table 1

[0037]

Embodiment 7～ Embodiment 10）

[0039] The preparation method of each embodiment is basically the same as that of Example 1, and the differences are shown in Table 2.

[0040] Table 2

[0041]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a preparation method of high-purity tolvaptan. The preparation method comprises the step of reducing N-[4-[(5R)-7-chloro-5-oxo-2,3,4,5-tetrahydro-1-benazepine-1-formyl]-3-methyl phenyl]-2-methyl benzamide with sodium bis(2-methoxyethoxy) aluminumhydride, thereby obtaining the high-purity tolvaptan with the purity higher than or equal to 99.95%. The preparation method disclosed by the invention has the advantages that sodium bis(2-methoxyethoxy) aluminumhydride is adopted as a reducing agent for preparing tolvaptan by reducing N-[4-[(5R)-7-chloro-5-oxo-2,3,4,5-tetrahydro-1-benazepine-1-formyl]-3-methyl phenyl]-2-methyl benzamide, the production of a dechlorination impurity IV can be extremely effectively inhibited, and finally the high-purity tolvaptan with the purity higher than or equal to 99.95% can be obtained, and high yield being 90% or above can be obtained while tetrahydrofuran or methyltetrahydrofuran is adopted as a reaction solvent.

Description

technical field [0001] The invention belongs to the technical field of medicine preparation, and in particular relates to a preparation method of high-purity tolvaptan. Background technique [0002] The chemical name of Tolvaptan is: N-[4-[(5R)-7-chloro-5-hydroxy-2,3,4,5-tetrahydro-1-benzazepine-1 -Formyl]-3-methylphenyl]-2-methylbenzamide, which was developed by Japan’s Otsuka Pharmaceutical Co. and was approved by the US FDA in 2009. Its trade name is Samsca®. For the treatment of hyponatremia caused by congestive heart failure, liver cirrhosis, and antidiuretic hormone deficiency syndrome. [0003] The structural formula of tolvaptan is shown in formula I: [0004] . [0005] I [0006] At present, the mainstream synthetic route of tolvaptan is to obtain the compound shown in formula II through a series of reactions, and then reduce the 5-ketocarbonyl group of the compound to the 5-hydroxyl group to obtain tolvaptan (see literature 1 ~ document 6). [0007] [...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07D223/16
CPCC07D223/16
Inventor 胡国宜胡锦平高永清李喜龙奚小金
Owner CHANGZHOU SUNLIGHT PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap